国新健康（000503）8月8日主力资金净流出1082.04万元

Core Insights - The stock price of Guo Xin Health (000503) closed at 10.6 yuan on August 8, 2025, reflecting a decline of 3.64% with a turnover rate of 3.09% and a trading volume of 302,500 hands, amounting to 324 million yuan in transaction value [1] Financial Performance - For the first quarter of 2025, Guo Xin Health reported total operating revenue of 50.47 million yuan, representing a year-on-year growth of 5.33% [1] - The net profit attributable to shareholders was 45.58 million yuan, showing a year-on-year decrease of 12.86% [1] - The company's non-recurring net profit was 45.57 million yuan, also down by 12.45% year-on-year [1] - Key financial ratios include a current ratio of 3.016, a quick ratio of 3.013, and a debt-to-asset ratio of 31.75% [1] Capital Flow - On the trading day, the net outflow of main funds was 10.82 million yuan, accounting for 3.34% of the transaction value [1] - The breakdown of fund flows included a net outflow of 3.39 million yuan from large orders (1.05% of transaction value), 7.43 million yuan from big orders (2.29%), and a net inflow of 18.98 million yuan from medium orders (5.86%) [1] - Small orders experienced a net outflow of 8.16 million yuan, which is 2.52% of the transaction value [1] Company Background - Guo Xin Health was established in 1987 and is located in Qingdao, primarily engaged in research and experimental development [2] - The company has a registered capital of approximately 9.84 billion yuan and a paid-in capital of about 9.81 billion yuan [1] - The company has made investments in 44 enterprises and participated in 22 bidding projects, holding 54 trademark registrations and 8 administrative licenses [2]